Attain Performa(TM) Quadripolar Lead Study

NACompletedINTERVENTIONAL
Enrollment

1,202

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Heart Failure
Interventions
DEVICE

Device: Attain Performa Pacing Lead (along with a standard CRT-D system)

Implant and follow-up of study lead, separate analysis for each lead model

Trial Locations (121)

Unknown

Glendale

Riverside

San Diego

San Jose

Standford

West Hollywood

Hartford

Atlantis

Boca Raton

Fort Lauderdale

Jacksonville

Orlando

Tampa

Atlanta

Chicago

Maywood

West Des Moines

Kansas City

Edgewood

Houma

Baltimore

Rockville

Boston

Ann Arbor

Lansing

Royal Oak

Minneapolis

Saint Cloud

Saint Louis Park

Tupelo

Kansas City

St Louis

Lincoln

Henderson

Morristown

Ridgewood

New York

Stony Brook

Charlotte

Durham

Winston-Salem

Fargo

Cleveland

Columbus

Oklahoma City

Tulsa

Medford

Erie

Lancaster

Pittsburgh

Wilkes-Barre

Wynnewood

Greenville

Spartanburg

Germantown

Kingsport

Nashville

Austin

Dallas

Houston

Plano

Temple

Burlington

Fairfax

Norfolk

Morgantown

Milwaukee

Randwick

Chermside

Adelaide

Heidelberg

Perth

Graz

Linz

Genk

Yvoir

Calgary

London

Montreal

Newmarket

Québec

Santiago

Århus N

Copenhagen

Helsinki

Nantes

Rennes

Rouen

Bad Rothenfelde

Bernau

Bielefeld

Chemnitz

Heidelberg

Trier

Athens

Budapest

Gurgaon

Dehli

Ashkelon

Bologna

Cefalù

Rovigo

Kuala Lumpur

Eindhoven

Maastricht

Nieuwegein

Bergen

Bucharest

Riyadh

Belgrade

Kamenitz

Niš

Bratislava

Košice

Ljublijana

Cape Town

Madrid

Lausanne

Bournemouth

London

Manchester

All Listed Sponsors
lead

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY

NCT01751022 - Attain Performa(TM) Quadripolar Lead Study | Biotech Hunter | Biotech Hunter